The Brenda Diener
Lung Cancer Biomarkers Program

Literature, news and videos pertinent to 
The Brenda Diener Lung Cancer Biomarkers Program

PAPILLON: Adding Amivantamab to First-Line Chemotherapy Prolongs Progression-Free Survival in NSCLC Subset
By The ASCO Post Staff
December 10, 2023 - Supplement: ESMO Highlights

National Lung Screening Trial Results Highlight Importance of Lifelong Follow-up
By The ASCO Post Staff
October 10, 2022 - Supplement: Conference Highlights IASLC 2022

Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) Centers for Medicare & Medicaid Services

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT)

powered by Surfing Waves

This website provides information about ICAN's Personalized Medicine Cancer Case Navigation Programs, while it also describes ICAN's multi-faceted mission, unique vision, and respected values. Intended for use by the general public, this site also offers more in-depth information for target populations who may benefit from ICAN's Program Services such as ICAN patients, their caregivers and medical teams - along with those healthcare professionals and researchers who are involved with ICAN's medical and scientific councils.

Information contained on ICAN's website does not purport to be medical advice for cancer patients nor for the general population. ICAN - a patient advocacy and educational organization - strives to convey well-sourced general information and encourages the patient to consult with his/her medical team on all treatment issues.

Information contained herein is therefore not intended to substitute for or supersede any advice that a patient receives from his/her health professional and is not intended to compromise in any way the patient-physician relationship. ICAN strongly believes that all medical decisions need to be made, via shared decision-making, by the patient and his/her medical team.

ICAN is a zealous implementer of HIPAA practices, meticulously keeping all patient and donor information strictly confidential. See Privacy Policy.

ICAN sponsors and advertisers are clearly indicated as such on this website.

If you have questions about this site, please contact We will be happy to respond.

The Brenda Diener Lung Cancer Biomarkers Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

For more information about this special program, please click on...

  1. Main
  2. About
  3. Photos
  4. Inspiration
  5. Memories


We are always looking for updated RSS newsfeeds for the The Brenda Diener Lung Cancer Biomarkers Program at ICAN. If you have suggestions, please email us at

Please encourage family and friends to join our Cancer Research Literature teams for this Program by emailing ICAN at  We would like additional Research Team Leaders at ICAN for this named program to be medical students, physicians, nurses, or post-doctoral students in the sciences.  

Web Research Interns for the The Brenda Diener Lung Cancer Biomarkers Program are comprised of highly motivated high school students, college students, college graduates, medical students, or employed or retired persons who have the time to help a great cause.  

Please submit two paragraphs about your background and career (and career aspirations) and why you would like to be part of an ICAN Research team.  All positions are "virtual" meaning you work from your home or office computer and email your work in Word (and in some cases Excel, but you need not be fluent in Excel to join us).  

Because ICAN has a global volunteer network, all positions are unpaid.  ICAN is five-star rated on VolunteerMatch.

If you have peer-reviewed citations to SUBMIT to this part of Brenda's Program, please email to

Guidestar Platinum Seal of Transparency 2021

Federal Tax I.D.: EIN 86-0818253